Setting up an organization and infrastructure for cross-research group analyzes of COVID vaccine immune response (Harmony project).

  • Funded by Netherlands Organisation for Health Research and Development (ZonMW)
  • Total publications:0 publications

Grant number: 1.04301E+13

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2023
    2024
  • Funder

    Netherlands Organisation for Health Research and Development (ZonMW)
  • Principal Investigator

    M. Knapen
  • Research Location

    N/A
  • Lead Research Institution

    Rijksinstituut voor Volksgezondheid en Milieu
  • Research Priority Alignment

    N/A
  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Characterisation of vaccine-induced immunity

  • Special Interest Tags

    Data Management and Data Sharing

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Other

  • Occupations of Interest

    Unspecified

Abstract

A large part of the Dutch population has been vaccinated against COVID-19. After vaccination, an immune response follows in the body. This is how immunity is built up. However, some people have a reduced immune system. This may be due to underlying conditions such as an innate immune disorder. Or by treating a disease. These people are at a higher risk of problems with a COVID-19 infection. We do not yet know well enough whether they are protected sufficiently and for a sufficiently long time after vaccination. With the help of this project, conditions are being set up under which data sharing between nine different research groups can take place in a good and safe manner. It is also ensured that everyone speaks the same language. A solution is being sought for all organizational and technical challenges that arise. This should lead to answers to research questions so that more people are better treated and protected in the event of a COVID-19 infection.